Phase II clinical trial - Pédiatrie Rétinoblastomes

RETINO-2018 (IC 2019-05)
Pédiatrie Rétinoblastomes
Ouvert depuis le: 05.25.2024
Site: Paris
Public cible
Enfant
Ocular Conservative Treatment for Retinoblastoma: Efficacy of the New Management Strategies and Visual Outcome - RETINO 2018
Description de l'essai
This protocol includes 2 independent studies. Both studies are multicenter studies, evaluating different therapeutic approaches in two different populations of patients:;Study 1, a randomized phase-II study evaluating the efficacy of Intra-Arterial Chemotherapy (IAC) with melphalan and topotecan versus melphalan alone, both in association with ophthalmologic treatments.;Study 2, a minimally invasive interventional study evaluating the results on visual function following reference treatment with intravenous (IV) chemotherapy in association with ophthalmologic treatments.
LIVIA LUMBROSO-LE ROUIC
Investigateur principal